CCL5 and urinary bladder neoplasm: CCL5 was upregulated in bladder tumor, urinary tract infection, reteropelvic junction obstruction, and IC.41–44 Since the tumor, infection, and information belonged to the content of exclusion criteria, CCL5 might be a potential biomarker for IC.